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Residual solvents in pharmaceutical samples are monitored using gas chromatography with head space. 
Based on good manufacturing practices, measuring residual solvents is mandatory for the release testing 
of all active pharmaceutical ingredients (API). The analysis of residual organic solvents (methanol, 
acetone, cyclohexane, dichloromethane, toluene) in Omeprazole, an active pharmaceutical ingredient was 
investigated. Omeprazole is a potent reversible inhibitor of the gastric proton pump H+/K+-ATPase. The 
Head space gas chromatography (HSGC) method described in this investigation utilized a SPBTM-624, 
Supelco, 30 m long x 0.25 mm internal diameter, 1.4µm-thick column. Since Omeprazole is a thermally 
labile compound, the selection of the proper injector temperature is critical to the success of the analysis. 
The injector temperature was set at 170°C to prevent degradation. The initial oven temperature was set 
at 40°C for 12 min and programmed at a rate of 10°C min−1 to a final temperature of 220°C for 5 min. 
Nitrogen was used as a carrier gas. The sample solvent selected was N,N-dimethylacetamide. The method 
was validated to be specific, linear, precise, sensitive, rugged and showed excellent recovery.
Uniterms: Headspace-gas chromatography. Omeprazole. Method validation. Residual solvents release 
testing. 
Solventes residuais em amostras farmacêuticas são monitoradas utilizando-se cromatografia a gás 
“headspace”. Com base nas boas práticas de fabricação, a medida de solventes residuais é obrigatória 
para o teste de liberação de todos os ingredientes farmacêuticos (API). Efetuou-se a análise de solventes 
orgânicos residuais (metanol, acetona, cicloexano, diclorometano, tolueno) em omeprazol, ingrediente 
farmacêutico ativo. O omeprazol é potente inibidor reversível da bomba de prótons H+/K+-ATPase. A 
cromatografia a gás “headspace” (HSGC) descrita nessa pesquisa utilizou um SPBTM-624, Supelco, de 
30 m de comprimento x 0,25 mm de diâmetro interno, e coluna de 1,4 µm de espessura. Considerando-
se que o omeprazol é termicamente lábil, a seleção da temperatura apropriada do injetor é crítica para 
impedir a degradação. A temperatura inicial do forno foi de 40 °C, por 12 minutos, e programada à taxa 
de acréscimo de 10 °C min−1 até a temperatura final de 220 °C, por 5 minutos. Nitrogênio foi utilizado 
como gás de transporte. Selecionou-se como solvente a N,N-dimetilacetamida. O método foi validado 
mostrando-se específico, linear, preciso, sensível, robusto e com excelente recuperação. 
Unitermos: Cromatografia a gás “headspace”. Omeprazol. Método de validação. Teste de liberação de 
solventes residuais. 
INTRODUCTION
Organic solvents are routinely applied during 
synthesis of drug substances, excipients, or during drug 
product formulation. They are not desirable in the final 
product, mainly because of their toxicity, influence on the 
quality of crystals of the drug substance, and their odor 
or taste, which can be unpleasant for patients. To remove 
them, various manufacturing processes or techniques 
(usually under increased temperature or/and decreased 
pressure) are in use. Even after such processes, some sol-
vents still remain, albeit in small quantities. These small 
quantities of organic solvents are commonly known as or-
ganic volatile impurities (OVIs) or residual solvents (RS). 
The determination of residual solvents in drug substances, 
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excipients or drug products is known to be one of the most 
difficult and demanding analytical tasks in the pharma-
ceutical industry. Furthermore, the determination of polar 
residual solvents in pharmaceutical preparations continues 
to present an analytical challenge mainly because these 
compounds are difficult to remove from water or polar 
solvents (ICH, 2002, 1997; Hymer, 2003). The manufac-
turing of active pharmaceutical ingredients (API) under 
GMP (good manufacturing practice) conditions requires 
adequate control of the quality of the different ingredients 
involved in the synthesis. Organic residual solvents must 
therefore be controlled, and their purity determined, before 
any GMP synthesis.
Inadequate attention has been paid during pharma-
ceutical investigations. Headspace gas chromatography 
(HSGC) is a technique where the liquid or solid sample is 
set in a closed vessel until the volatile components reach 
equilibrium between the sample and the gas volume above, 
i.e., the so called “headspace”. An aliquot of the headspace 
is sampled and introduced into a gas chromatographic 
(GC) column for analysis. Regulatory agencies and phar-
macopoeias suggest headspace gas chromatography as 
the most suitable technique for residual solvent testing 
for active substances and formulations soluble in water. 
Residual solvent specification limits, set in accordance 
with the toxicity of solvents, vary from a few ppm to thou-
sands of ppm. HSGC determination of residual solvents 
is nowadays a mature technique (Grodowska et al., 2010; 
Puranik et al., 2009; Groman et al., 2008; Alzaga, 2007; 
Camarasu, 2006; Michulec et al. 2005; Rocheleau et al., 
2004; Klick, 2004; Snow, 2002; Hymer et al., 2003; Iofer 
et al., 1984).
Direct injection of analytes evaporated through 
equilibration between liquid (or solid) phase and gas phase 
into a GC system minimized the contamination of the GC 
system and the deterioration of the GC column (Kolb et 
al.,1997). In addition, the automation of equilibrium and 
injection procedure reduced analysis time and improved 
reproducibility in the injection procedure.
Omeprazole is a potent reversible inhibitor of the 
gastric proton pump H+/K+-ATPase. The molecular struc-
ture of omeprazole is illustrated in Figure 1.
It is composed of a substituted pyridine ring linked 
to a benzimidazole by a sulfoxide chain. Chemically 
designed as 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-
pyridinyl)methyl]sulfinyl]-1H-benzimidazole. Omeprazo-
le is a white powder, slightly soluble in water, but is highly 
soluble in alkaline solutions as the negatively charged 
ion. It is an ampholyte with pKa=4 (pirydinium ion) and 
8.8 (benzimidazole). In solution, Omeprazole degrades 
rapidly at low pH values, and it is photo and heat sensitive 
(Sarisuta et al., 1997). Its molecular formula and weight 
is C17H19N3O3S, and 345.4, respectively (Marzocchi et 
al., 2001). Omeprazole is known for its high potential to 
interact with other drugs (United States Pharmacopoeia, 
2006; Anderson, 1996; Mayer,1996). The aim of this study 
was to develop a HSGC method for analysis of residual 
solvents in omeprazole API. The residual solvents were 
compared to standard solvents and the ICH standard resi-
dual solvents limit.
EXPERIMENTAL
Material
Used Chemicals were obtained from the following 
suppliers: methanol (sigma-aldrich, Mumbai, India), 
acetone, cyclohexane, dichloromethane (DCM) and to-
luene (Qualigens, Mumbai, India) N,N-dimethylacetamide 
(DMA) HPLC grade (Spectrochem, Mumbai, India). 
Omeprazole API was obtained from Shipra Pharma, 
Mumbai, India.
Instrumentation
A Gas chromatograph (Agilent technologies 6890N) 
equipped with a flame ionization detector, a Headspace 
sampler (Agilent technologies G1888) was used to load 
the sample. An analytical balance (XS 205 from Mettler 
Toledo) and autopippette (100 – 1000 µL from Eppendorf) 
were used. The headspace injector and GC conditions are 
provided in Table I.
Chromatographic conditions
A volume of 1ml standard and sample solution was 
injected into the GC injection port. The temperature of the 
injection port was maintained at 170 °C at a split ratio of 
1:10, with nitrogen as a carrier gas. The pressure was main-
tained at 14 psi with flow of 1 mL min-1. The temperature 
of the detector was set at 250 °C. Temperature gradient was 
maintained at 40 °C for twelve min and then increased at 
a rate of 10 °C min-1 up to 220 °C to a final temperature of 
220 °C and maintained for 5 min.FIGURE 1 – Structural formula of omeprazole.
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TABLE I - Headspace injector and GC conditions
Headspace injector Gas Chromatography
Oven equilibration temperature 80°C Column SPBTM-624, Supelco, 30 m length, 
0.25 mm internal diameter, and 1.4 µm 
film thickness
Loop temperature 90°C Carrier gas Nitrogen
Transfer line temperature 100°C Flow rate 1.0 mL per minute (Linear velocity 
26 cm/sec)
GC cycle time 45 min Injector temperature 170 °C
Oven/vial, equilibration time 30 min Detector temperature 250 °C
Pressurization time 0.5 min Split ratio 1:10
Loop fill time 1.0 min Oven temperature program Initial 40 °C, held for 12 minutes
Injection time 0.5 min Increase @ 10 °C per minute to 220 °C
Loop equilibration time 0.5 min Held at 220 °C for 5 minutes
Vial pressure 14 psi
Preparation of standard and sample vial
DMA was selected as the standard and sample di-
luent because of its ability to dissolve a wide variety of 
substances. It has a high boiling point that does not interfe-
re with more volatile solvents, analyzed by GC. A common 
standard stock solution in DMA containing all the known 
residual solvents of Omeprazole API (i.e., methanol, 
acetone, cyclohexane, dichloromethane and toluene) was 
prepared in such a way that it had a final concentration of 
3000 ppm for methanol, 5000 ppm for acetone, 100 ppm 
for dichloromethane, 890 ppm for toluene and 3880 ppm 
for cyclohexane.
The standard vial was prepared with 1 mL of the stan-
dard solution and the sample vials were prepared with ap-
proximately 120 mg of sample with 1 mL DMA as diluent.
Method validation
The method validation was done by evaluating spe-
cificity, limit of detection (LOD) and limit of quantitation 
(LOQ), linearity, accuracy, repeatability, ruggedness, sys-
tem suitability and method precision of residual solvents 
as indicated in the ICH harmonised tripartite guideline 
(1997, 2002).
RESULT AND DISCUSSION
Specificity
The omeprazole API sample was spiked with dichlo-
romethane, toluene, methanol, cyclohexane and acetone 
individually, and each sample was chromatographed to 
examine interference, if any, of the residual solvent peaks 
with each other. The retention time for standard methanol, 
acetone, dichloromethane, cyclohexane and toluene was 
found to be 3.41, 5.23, 6.24, 12.14 and 18.26 min, res-
pectively. A typical chromatogram of standard solution is 
shown in Figure 2.
Linearity
The linearity of the method was determined by 
making injections of each residual solvent over the range 
15-150% LOQ. Three replicates were performed at each 
level. The calibration curves were obtained with the ave-
rage of peak area ratios of three replicates. The correlation 
coefficient (r2) values for all residual solvents were found 
to be higher than 0.997 and the calibration curves were 
linear within the range. Table II shows the linearity values 
for the residual solvents.
FIGURE 2 - Typical chromatogram showing retention time for 
different residual solvents. A-methanol, B-acetone, C-DCM, 
D-cyclohexane, E-toluene.
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Limit of Detection (LOD) and Quantitation (LOQ)
The LOD and LOQ were calculated by instrumental 
and statistical methods. For the instrumental method, LOD 
is determined as the lowest amount to detect, and LOQ is 
the lowest amount to quantify, by the detector. The LODs 
of residual solvents in Omeprazole API were determined 
based on a signal-to-noise ratio of 3:1. The LOQs of resi-
dual solvents were determined based on a signal-to-noise 
of ratio 10:1. The values for the LOD and LOQ for dichlo-
romethane, toluene, methanol, cyclohexane and acetone 
are shown in Table II.
Accuracy (recovery)
A known amount of sample (120 mg) was taken 
separately in five different vials and spiked with known 
quantities of DCM, toluene, methanol, cyclohexane and 
acetone at three different levels (50, 100 & 150 % of Quan-
tization Limit) in triplicate. The results are presented in 
Table III. From accuracy data, the % recovery of residual 
solvents was found within the limits (80-120%) and % 
RSD for area did not exceed 10.0 for each solvent as per 
the ICH guideline. Results indicate that the method has an 
acceptable level of accuracy.
Precision
For the system precision, a single injection of blank 
and six replicate injections of standard solution were ob-
served. Intermediate precision study was carried out by a 
different analyst, on a different instrument and on another 
day. Table IV shows the results for intermediate precision. 
The % RSD for each solvent was found to be less than 10 
and system suitability was passed.
Robustness
To demonstrate the robustness of the method, the 
system suitability criteria with slight variations in method 
parameters, was verified. The following parameters were 
changed: column oven temperature ± 5 ºC from the ideal 
conditions (initial column oven temperature at 35 °C and 
45 °C), the flow rate ± 10% from the ideal conditions (flow 
rate 0.9 mL/min and 1.1 mL/min), the split ratio ± 10% 
from the ideal conditions (the split ratio of 1:9 and 1:11), 
two columns of different serial numbers. The results are 
shown in Table V. For the robustness study, individual 
%RSD should not exceed 10.0 and cumulative (overall) 
% RSD should not exceed 15.0, for each component, and 
system suitability should pass.
System suitability
The system suitability criterion was taken to be the 
resolution between the critical pairs, i.e., acetone and di-
chloromethane. The system suitability was evaluated by 
injecting the standard solution on various days before star-
TABLE II - Validation results for residual solvents
Solvent Specificity Linearity Limit of 
Detection (LOD) 
(ppm)
Limit of 
Quantitation (LOQ) 
(ppm)
RT (min.) Slope Intercept Correlation 
coefficient (r2)
MeOH 3.41 0.08 5.33 0.998 1.03 2.89
Acetone 5.23 0.27 1.98 0.999 2.18 4.25
DCM 6.24 0.06 0.20 0.998 0.96 2.58
Cyclohexane 12.14 1.07 9.30 0.999 1.19 3.16
Toluene 18.26 0.20 2.58 0.997 1.03 2.82
TABLE III - Accuracy data for different residual solvents
Spiking level 
(% of QL)
MeOH 
(% recovery)
Acetone 
(% recovery)
DCM 
(% recovery)
Cyclohexane 
(% recovery)
Toluene 
(% recovery)
50% 106.12 101.12 111.12 100.12 96.12
100% 97.02 94.2 100.2 99.4 97.4
150% 100.94 100.94 108.94 98.94 98.14
% Average 
Recovery 
101.94±4.56 98.75±3.94 106.75±5.77 99.49±0.6 97.22±1
% RSD 4.47 3.99 5.40 0.6 1.03
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TABLE IV - Intermediate precision data
Intermediate Precision
MeOH Acetone DCM Cyclohexane Toluene
Mean (ppm) 144.60 972.5 5.87 2970 125
SD 12.05 18.60 0.14 30.24 9.76
%RSD 8.33 1.91 2.39 1.02 7.8
TABLE V - System suitability under robustness condition
Conditions % RSD for standard solution under different robustness conditions
MeOH Acetone DCM Cyclohexane Toluene
Control 5.74 1.42 2.41 0.79 5.89
Oven temp. decrease 3.85 1.89 2.32 1.62 4.18
Oven temp. increase 7.65 3.48 5.07 2.58 8.59
Flow decrease 2.95 1.62 2.44 2.04 4.07
Flow increase 5.32 4.27 2.56 2.88 4.91
Split Ratio decrease 4.30 2.78 3.33 3.30 5.40
Split Ratio increase 2.18 1.51 2.63 1.18 2.30
Column change 7.92 3.88 5.17 6.21 9.06
TABLE VI - System suitability
Experiment Resolution between acetone 
and dichloromethane
Specificity 1.943
Precision 1.939
Accuracy 1.941
Linearity 1.911
LOD/LOQ 1.949
ting any exercise during the validation study. The criterion 
for system suitability was that the resolution between the 
above-mentioned critical pair should not be less than 1.5 
and it was found to be well above the minimum passing 
limit (Table VI).
CONCLUSION
A single, rapid and highly selective HSGC method 
was developed and validated for the quantification of 
residual solvents present in Omeprazole API through an 
understanding of the synthetic process, nature of solvents 
and nature of stationary phases of columns. The residual 
solvents methanol, acetone, cyclohexane, dichloromethane 
and toluene were determined. The developed method is 
specific, accurate, precise and rugged as per ICH guidelines.
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